Skip to main content

Biotechnology

  • Opportunity for B.Pharm/M.Pharm/M.Sc (19 posts) in R&D at Indian Institute of Integrative Medicine

    Indian Institute of Integrative Medicine (IIIM) is a national Institute of the Council of Scientific & Industrial Research (CSIR) of India, with primary focus of research on drug discovery from natural products (medicinal plants and microbial species). IIIM is a multi-disciplinary organization encompassing the natural products chemistry, medicinal chemistry, pharmacology, microbiology, biotechnology and botanical sciences.

  • Wanted M.Pharm candidates for post of Junior Research Fellow at Andhra University

    Applications are invited for one Junior Research Fellow for the DST-SERB Project entitled “Synthesis and Screening of Novel Lamellarin Analogues as Potential Agents Against Mycobacterium tuberculosis’’.

    Post: Junior Research Fellow

    [adsense:336x280:8701650588]

  • Jobs for freshers as Research Intern (5 posts) at HLL Lifecare - Enterprise under MOHFW, Govt. of India

    HLL Lifecare Limited, a Mini Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare, Govt. of India is a global provider of high quality healthcare products & services. With state-of-the-art manufacturing facilities spanning across India, HLL is diversifying into vaccine manufacturing, lifecare services, sanitary napkins besides engaging in procurement consultancy, healthcare infrastructure development and facility management.

  • Career in PGIMER to study primary immune deficiency diseases - M.Sc/M.Pharm/Ph.D

    The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage. The institute started in 1962 and Pt Jawahar Lal Nehru inaugurated the hospital now named “Nehru Hospital” on 7th July 1963. The Institute was originally under the Government of undivided Punjab. After the reorganization of the state, the administrative control of the institute passed on to the Union Territory of Chandigarh in November 1966. The Institute became an autonomous body under the Act of Parliament in 1967 functioning under the Ministry of Health and Family Welfare, Government of India.

  • Vacancies of Research positions for pharma students at IIT

    In keeping with India's vision to become a world leader in Science and Technology and to usher in a new revolution, resulting in an unprecedented economic growth, Government of India reassessed the need of technical manpower and decided to set up eight new IITs. Six of them started functioning back from the academic year 2008-09. These were established at Hyderabad, Gandhinagar, Rajasthan, Ropar, Patna and Bhubaneswar. IIT Indore and IIT Mandi started functioning from July 2009.

  • GGSIP University looking for young researchers for pursuing research in the area of Pharmaceutical

    Guru Gobind Singh Indraprastha University is a dynamic growth oriented organization established to facilitate and promote studies and research in emerging areas of higher education with focus on professional education. The University imparts education in the field of Engineering, Science, Technology, Humanities & Social Sciences etc. at Graduate, Post-Graduate, and Doctorate Level under its various Schools.

    CEPS established under the aegis of GGSIP University is engaged in research / teaching in Pharmaceutical Chemistry / Pharmacology / Microbiology & Bioethics. CEPS is looking for meritorious young researchers for pursuing research in the area of Pharmaceutical Chemistry, Detection, Isolation, Structural Elucidation & Biological Screening.

  • PharmaTutor Magazine - January 2016 is released | Subscribe today
  • REGENXBIO Inc.  a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy,  announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation to RGX-111, the Company’s investigational gene therapy product candidate for the treatment of mucopolysaccharidosis Type I (MPS I).

  • International Conference on developing pharmacy education - a policy and practice perspective at RIPER
  • Walk-in at Vallabhbhai Patel Chest Institute, University of Delhi as Research Associate

    The Vallabhbhai Patel Chest Institute (VPCI) is a unique postgraduate medical institution devoted to the study of chest diseases. It is a University of Delhi maintained institution and is funded entirely by the Ministry of Health and Family Welfare, Government of India. The institute is ideally located in the heart of the main campus of the University of Delhi, providing the requisite academic environment.

Subscribe to Biotechnology